Careers  |  Sign In  |  Register  |   Twitter

Latest in Pathology & Lab Medicine

Waiting lists for organ transplantation may become a relic of the past thanks to this experimental organ repurposing process.
[case_player][/case_player] In 2015, Chinese biotechnology company Revotek released a 3d-bioprinter that fabricates blood vessels using a bio-ink made from stem cells. Just before the close of 2016, Kang Yujian, chief scientist and CEO of Revotek, announced the first successful transplant of bioprinted...